Considerations Regarding RNA Extraction Kits for SARS-CoV-2 Detection

The novel coronavirus disease (COVID-19) pandemic continues to trigger rapid development of molecular diagnostic tests around the world. Nucleic acid amplification-based tests (NAATs)—such as real-time PCR and isothermal amplification—are the gold standard in molecular diagnostic technologies that are being utilized to detect SARS-CoV-2, the COVID-19 disease-causing virus.1 There are two critical and sequential steps that […]

Read More…

How to Choose an Assay Development Platform

The Luminex Team knows assay development. Check out some tips from our experts below. If you need to design a new assay, there are several factors you’ll want to consider before selecting the platform you’ll develop it on. Based on our experience, these are the most important: Analyte of interest: Is your assay meant to […]

Read More…

The Faces of Luminex: Kurt Hoffacker, Chemistry R&D

Developing immunoassay technology and platforms takes innovation and hard work on a number of fronts—hardware, software, reagents, and more. We count on Kurt Hoffacker, Director of Chemistry R&D, to ensure that reagent development goes smoothly, and ultimately leads to products that integrate well with the rest of the Luminex systems. He has been a key […]

Read More…

3D Organoid Cultures Offer Clues to Heterogeneous Therapy Response in Cancer Patients

Luminex-powered DigiWest® assays show significant intratumoral differences in response A publication in PLoS Genetics sheds much-needed light on the heterogeneity of drug response within tumors. The scientists used organoid cultures with several analytical tools, including DigiWest protein expression assays, which are based on xMAP® Technology from Luminex. “Heterogeneous pathway activation and drug response modeled in […]

Read More…

MAGPIX® Systems See New Life Through Equipment Donation Program

MilliporeSigma and Seeding Labs send gently used instruments to labs in need Thanks to a nonprofit organization called Seeding Labs and our Licensed Technologies Partner MilliporeSigma, previously-owned xMAP® Technology systems are helping scientists in laboratories in developing countries around the world answer important new research questions. Seeding Labs is a Boston-based nonprofit dedicated to empowering […]

Read More…

METHODS Journal: A New Multiplexing Protocol Performs Protein and Gene Level Measurements on a Single Luminex Platform

Researchers demonstrate a high-throughput method for measuring mRNA and proteins using the Luminex xMAP® Platform You shouldn’t have to choose between analyzing gene expression or screening for proteins. In a Methods publication, researchers demonstrate how to measure mRNA expression and analyze proteins with a single sample set using Luminex xMAP® Technology. The article comes from […]

Read More…

Rare but Not Alone – Raising Awareness for Rare Diseases

Join us on Rare Disease Day to honor patients, caregivers, doctors, and scientists. On February 29—a day that only occurs once every four years—people around the world will celebrate Rare Disease Day. It’s a special opportunity to think about those who are affected by rare diseases, the researchers and physicians who work to help them, […]

Read More…

The Faces of Luminex: Johanna Takach, Advanced Technologies

Our Advanced Technologies Group is responsible for scouting emerging technology and new directions for future development at Luminex. That’s a big task, so we rely on team members like Johanna Takach, Scientist II, to provide valuable guidance for accomplishing it. She joined Luminex in 2015 after earning her bachelor’s degree in agricultural biotechnology from the […]

Read More…

Webinar: Fast, Economical Malaria Testing with xMAP® Technology

Multiplex assay allows for detailed investigations of transmission and drug resistance Multiplexing technology from Luminex has been critical for the development of assays designed to study human SNPs involved in parasite transmission as well as the spread of drug resistance markers in Plasmodium falciparum. That was a key message in this presentation from Lynn Grignard, […]

Read More…

Webinar: Multiplex Serological Assay Developed to Identify Avian Influenza Subtypes

Rapid detection could help prevent transmission and reduce flock losses In addition to being a public health threat, avian influenza is also costly and potentially devastating to people whose livelihoods depend on raising poultry. To enable faster detection of bird flu and identification of its subtypes, scientists at Wageningen Bioveterinary Research in The Netherlands developed a […]

Read More…